Start where the gap is. Expand when ready.
Extend the program already in place or use Burse™ as the complete operating platform.
Extend Your Current Program
For health plans with existing vendors, analytics, or internal opportunity sources. Burse™ preserves those inputs, independently identifies additional condition and documentation opportunities, and manages eligible actionable findings through one accountable workflow.
Use the Complete Burse™ Platform
For organizations that need condition discovery, documentation integrity review, accountable workflow, dashboards, reporting, and verified closure in one Burse™-led operating platform.
Prove incremental value before changing what already works.
Start with a defined population and the opportunity baseline already produced by the health plan’s current environment. Burse™ performs its analysis in parallel, preserves source attribution, and distinguishes overlapping findings from Burse™-unique condition and documentation opportunities. The client can validate the incremental results and workflow fit using its own data before expanding deployment.
- Define the evaluation population
- Establish the existing opportunity baseline
- Run Burse™ analysis in parallel
- Compare overlapping and Burse™-unique findings
- Validate clinical value and workflow fit
- Expand when the results support it
How the integrated model works
Burse™ keeps source attribution intact while adding independent clinical intelligence and an accountable workflow across eligible opportunities.
Preserve existing sources
Bring eligible findings already identified by current vendors and internal processes into Burse™ without replacing the sources that work.
Run Burse™ analysis
Burse™ independently analyzes longitudinal clinical and operational data to identify additional condition and documentation opportunities.
Maintain source attribution
Each finding retains its source so overlapping, Burse™-unique, and existing-source-only opportunities remain distinguishable.
Coordinate accountable action
Eligible actionable findings move through ownership, routing, dashboards, reporting, tracking, and verified closure.
Independent analysis can reveal incremental value after an existing review process.
Initial findings from a limited 25-encounter evaluation. Results are sample validation findings, not a universal production benchmark.
“In a 25-encounter evaluation, Burse™ performed a third-pass analysis after certified coder and independent peer review, identifying additional documentation integrity issues, missed capture opportunities, and documentation needs that were reviewed and confirmed through client validation.”
25 de-identified encounters • Certified coder review + independent peer review • Burse™ AI third-pass analysis • Findings reviewed through client validation
Average estimated opportunity per reviewed encounter
Not documented/coded for capture
Present in documentation; missing from claim
Billed diagnoses with weak MEAT/supportability
24 condition-level opportunities surfaced across 25 encounters
This evaluation provides sample results from a limited review, not a universal production benchmark. Each client deployment is validated on its own data before go-live.
Preserve the baseline. Make incremental value visible.
Burse™ preserves where each finding originated so clients can distinguish opportunities already present in their baseline from findings Burse™ independently identifies.
Existing source only
Already present in a vendor or internal baseline. Burse™ provides workflow and reporting without clinical reanalysis or a shared-value fee.
Burse™ and existing source
Independently identified by both Burse™ and an existing source. Burse™ clinical insight is available, but no shared-value fee applies.
Burse™-unique
Independently identified only by Burse™. Shared-value treatment applies when accepted and again at verified closure.
Additional clinical context
Additional non-HCC or same-HCC context is shown without workflow, dashboards, or shared-value treatment.
A transparent model tied to incremental value.
Implementation and platform fees support the operating layer. Shared-value fees apply only to Burse™-unique findings that the client accepts to move forward.
Implementation
A one-time fee supports data setup, opportunity-source mapping, workflow configuration, validation, and training.
Platform
A monthly PMPM fee supports workflow, routing, ownership, dashboards, reporting, tracking, and closure management.
Shared Value
An initial shared-value fee applies when the client accepts a Burse™-unique condition opportunity or documentation integrity issue to move forward. An additional shared-value fee applies when the accepted opportunity reaches verified closure.
Finding treatment by source
“Existing source” includes findings already identified by a current vendor or internal process.
Burse™ can also provide condition discovery, documentation integrity review, accountable workflow, dashboards, reporting, and verified closure as a complete Burse™-led platform.
See how Burse™ can strengthen your current program.
Review your current opportunity sources, clinical-intelligence gaps, workflow responsibilities, and a low-risk path for evaluating Burse™ alongside what is already in place.